Cargando…
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
Heart failure (HF) and atrial fibrillation (AF) are common conditions that share similar clinical phenotype and frequently coexist. The classification of HF in patients with preserved ejection fraction (> 50%, HFpEF), mid-range reduced EF (40%−49%, HFmrEF) and reduced EF (< 40%, HFrEF) are cru...
Autores principales: | Chourdakis, Emmanouil, Koniari, Ioanna, Velissaris, Dimitrios, Tsigkas, Grigorios, Kounis, Nikolaos G, Osman, Neriman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185444/ https://www.ncbi.nlm.nih.gov/pubmed/34149825 http://dx.doi.org/10.11909/j.issn.1671-5411.2021.05.008 |
Ejemplares similares
-
Incidence, pathophysiology, predictive factors and prognostic implications of new onset atrial fibrillation following transcatheter aortic valve implantation
por: Koniari, Ioanna, et al.
Publicado: (2018) -
Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management
por: Koniari, Ioanna, et al.
Publicado: (2021) -
Effect of atrial fibrillation on cognitive function in heart failure patients
por: Ktenopoulos, Nikolaos, et al.
Publicado: (2021) -
Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
por: Koniari, Ioanna, et al.
Publicado: (2023) -
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
por: Koniari, Ioanna, et al.
Publicado: (2021)